Predicting autoimmunity after alemtuzumab treatment of multiple sclerosis. [electronic resource]
Producer: 20140813Description: 795-8 p. digitalISSN:- 1468-330X
- Adolescent
- Adult
- Alemtuzumab
- Antibodies, Monoclonal, Humanized -- adverse effects
- Autoimmune Diseases -- blood
- Autoimmunity -- drug effects
- Biomarkers -- blood
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Interleukins -- blood
- Male
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Predictive Value of Tests
- Young Adult
- Interleukin-21
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.